i
V-safe active surveillance for COVID-19 vaccine safety. Version 6, October 21, 2022
-
October 21, 2022
Details:
-
Corporate Authors:
-
Description:V-safe is an active surveillance program to monitor the safety of COVID-19 vaccines during the period when the vaccines are authorized for use under Food and Drug Administration (FDA) Emergency Use Authorization (EUA) and possibly early after vaccine licensure. V-safe is a new smartphone-based system that uses text messaging to initiate web-based survey monitoring in the form of periodic health check-ins to assess for potential adverse events following vaccination. CDC will use the follow-up capability of the existing Vaccine Adverse Event Reporting System (VAERS) call center to conduct active telephone follow-up on recipients reporting significant, medically attended health impacts during v-safe health check-ins. The purpose of v-safe surveillance is to rapidly characterize the safety profile of COVID-19 vaccines when given outside a clinical trial setting and to detect and evaluate clinically important adverse events and safety issues that might impact policy or regulatory decisions.
v-safe-protocol-v6-508.pdf
-
Subjects:
-
Document Type:
-
Name as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: